Rett syndrome: Evidence for normal dopaminergic function

Neuropediatrics

Volumn 27, Issue 5, 1996, Pages 256-259

  Wenk, Gary L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Basal ganglia; Dopamine; Neocortex; Receptors; Rett syndrome; Reuptake sites

Indexed keywords

DOPAMINE; HOMOVANILLIC ACID;

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DOPAMINERGIC SYSTEM; EXTRAPYRAMIDAL SYNDROME; HAND MOVEMENT; HUMAN; NEOCORTEX; PRESCHOOL CHILD; PRIORITY JOURNAL; RETT SYNDROME; SCHOOL CHILD; STEREOTYPY;

EID: 0029823083     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-973774     Document Type: Article

References (32)

1. Andersen, P. H.: Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex J. Neurochem. 48 (1987) 1887-1896
2. Armstrong, D. L., B. Antalffy, C. Hubbard, J. K. Dunn: Golgi studies of cortical areas in Rett syndrome J. Neuropathol. Exp. Neurol. 52 (1993) 284-286
3. Armstrong, D D.: The neuropathology of Rett syndrome - Overwiew 1994. Neuropediatrics 26 (1995) 100-104
4. Bauman, M. L., T. K. Kemper: Pervasive neurological abnormalities of the brain in Rett syndrome: A second case J. Neuropathol. Exp. Neurol. 51 (1992) 340
5. Brucke, T., E. Sofic, W. Killian, A. Rett, P. Riederer: Reduced concentrations and increased metabolism of biogenic emmins in a single case of Rett syndrome. A post mortem brain study. J. Neural. Trans. 68 (1987) 315-329
6. Chiron C., C. Bultreau, C. Loc'h, C. Raynaud, B. Garreau, A. Syrota, B. Maziere: Dopaminergic D2 receptor SPECT imaging in Rett syndrome: Increase of specific binding in striatum. J. Nucl. Med. 34 (1993) 1717-1721
7. Creese, I., C. M. Fraser: Structure and function of dopamine receptors. Alan R. Liss, New York (1986)
8. Dawson, T. M., D. R. Gehlert, R. T. McCabe, A. Barnett, J. K. Wamsley: D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J. Neurosci. 6 (1986) 2352-2365
9. Hagberg, B., J. Aicardi, K. Dias, O. Ramos: A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett syndrome: Report of 35 cases. Ann. Neurol 14 (1983) 471-479
10. Hagberg, B., F. Goutieres, F. Hanefeld, A. Rett, J. Wilson: Rett syndrome: criteria for inclusion and exclusion. Brain Dev. 7 (1985) 372-373
11. Hagberg, B., I. Witt-Engerstrom: Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am. J. Med. Gen 24 (1986) 47-59
12. Jellinger, K., D. Armstrong, H. Y. Zoghbi, A. K. Percy: Neuropathology of Rett syndrome. Acta Neuropathol. 76 (1988) 142-158
13. Kitt, C. A., J. C. Troncoso, D. L. Price, S. Naidu, H. W. Moser: Topological changes in substantia nigra and basal forebrain neurons in Rett syndrome Ann. Neurol. 28 (1990) 416-417
14. Lekman, A., I. Witt-Engerstrom, J. Gottfries, B. Hagberg, A. K. Percy, L. Svennerholm: Rett syndrome: Biogenic amines and metabolites in post-mortem brain Pediatr. Neurol. 5 (1989) 357-362
15. Lekman, A., I. Witt-Engerstrom, B. Holmberg, A. Percy, L. Svennerholm, B. Hagberg: CSF and urine biogenic amine metabolites in Rett syndrome. Clin. Genet 37 (1990) 173-178
16. Lowry, O. H., N. J. Rosenbrough, A. L. Farr, R. J. Randall: Protein measurement with folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
17. Naidu, S., D. F. Wong, C. Kitt, G. Wenk, H. W. Moser: Positron emission tomography in the Rett syndrome: clinical, biochemical and pathological correlates. Brain Dev. 14 (1992) S75-S79
18. Nielsen, J. B., A. Bertelsen, H. C. Lou: Low CSF HVA levels in the Rett syndrome: A reflection of restricted synapse formation? Brain Dev. 14 (1992) S63-65
19. Nomura, Y., M. Segawa, M. Higurashi: Rett syndrome and early catecholamine and indolamine deficient disorder. Brain Dev. (Tokyo) 7 (1985) 334-341
20. Perry, T. L., H. G. Dunn, H. H. Ho, J. U. Crichton: Cerebrospinal fluid values for monoamine metabolites, gamma ammobutyric acid, and other amino compounds in Rett syndrome. J. Pediatr. 112 (1988) 234-238
21. Reiss, A. L., F. Faruque, S. Naidu, M. Abrams, T. Beaty, R. N. Bryan et al. Neuroanatomy of Rett syndrome: A volumetric imaging study. Ann. Neurol. 34 (1993) 227-334
22. Rett Syndrome Diagnostik Criteria Work Group: Diagnostic criteria for Rett syndrome. Ann. Neurol. 23 (1988) 425-428
23. Rett, A.: Über ein zerebral-atrophisches Syndrom bei Hyperammonämie. Wien. Med. Wschr. 116 (1966) 723-726
24. Riederer, P., T. Brucke, E. Sofic, E. Kienzl, K. Schnecker, V. Schay, P. Kruzik et al: Neurochemical aspects of the Rett syndrome. Brain Dev. 7 (1985) 351-360
25. Riederer, P., M. Weiser, I. Wichart, B. Schmidt, W. Killian, A. Rett: Preliminary brain autopsy findings in progredient Rett syndrome. Am. J. Med. Genet. (Suppl. 1) (1986) 305-315
26. Terai, M., K. Hidaka, Y. Nakamura: Comparison of [3H]YM-09151 with [3H]spiperone and [3H]raclopride for dopamine D-2 receptor binding to rat striatum. Eur. J. Pharmacol. 173 (1989) 177-182
27. Wenk, G. L., D. J. Pierce, R. G. Struble, D. L. Price, L. C. Cork: Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiol. Aging 10 (1989) 11-19
28. Wenk, G. L., S. Naidu, M. F. Casanova, C. A. Kitt, H. Moser: Altered neurochemical markers in Rett's syndrome. Neurology 41 (1991) 1753-1756
29. Wenk, G. L., M. O'Leary, C. B. Nemeroff, G. Bissette, H. Moser, S. Naidu: Neurochemical alterations in Rett syndrome. Brain Res. 74 (1993) 67-72
30. Wenk, G. L : Alterations in dopaminergic function in Rett syndrome. Neuropediatrics 26 (1995) 123
31. Zoghbi, H. Y., A. K. Percy, D. G. Glaze et al: Reduction of biogenic amine levels in the Rett syndrome. N. Engl J Med 313 (1985) 921-924
32. Zoghbi, H. Y., M. Sheldon, I. J. Butler, E. O'Brian Smith, S. Kaufman, D. G. Glaze, A. K. Percy: Cerebrospinal fluid biogenic amines and biopterm in Rett syndrome. Ann. Neurol. 25 (1989) 56-60